杏林製薬(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4569/E00985-
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2022/08/12日証協無担保100株-97.44%0株0%800株-84.91%
2022/08/12日証協有担保159,500株+273.87%111,602株+96.48%18,100株-79.16%
2022/08/05日証協無担保3,900株+56%0株0%5,302株+278.71%
2022/08/05日証協有担保42,662株-72.33%56,802株+50.07%86,872株+136.41%
2022/07/29日証協無担保2,500株+31.58%0株0%1,400株+1066.67%
2022/07/29日証協有担保154,200株+31.02%37,851株-51.9%36,746株-55.19%
2022/07/22日証協無担保1,900株-95.45%0株0%120株-93.28%
2022/07/22日証協有担保117,692株+81.35%78,700株-33.12%82,000株+176.09%
2022/07/15日証協無担保41,800株+2222.22%0株0%1,786株+793%
2022/07/15日証協有担保64,896株+34.83%117,676株+192%29,700株-37.08%
2022/07/08日証協無担保1,800株-14.29%0株0%200株-33.33%
2022/07/08日証協有担保48,132株-23.11%40,300株+266.36%47,200株-69.09%
2022/07/01日証協無担保2,100株-60.38%0株0%300株-57.14%
2022/07/01日証協有担保62,600株+125.99%11,000株-86.66%152,700株+375.7%
2022/06/24日証協無担保5,300株-43.62%0株0%700株-80%
2022/06/24日証協有担保27,700株-68.17%82,475株+13.29%32,100株-53.81%
2022/06/17日証協無担保9,400株-8.35%0株0%3,500株+25%
2022/06/17日証協有担保87,031株+2723.85%72,800株-48.19%69,500株+279.78%
2022/06/10日証協無担保10,256株+1951.2%0株0%2,800株+211.11%
2022/06/10日証協有担保3,082株-94.51%140,500株+4%18,300株-6.39%
2022/06/03日証協無担保500株+66.67%0株0%900株-90.22%
2022/06/03日証協有担保56,157株-68.02%135,100株-6.76%19,550株-39.66%
2022/05/27日証協無担保300株-88.46%0株0%9,200株+666.67%
2022/05/27日証協有担保175,621株+133.98%144,900株+2.37%32,400株+32.24%
2022/05/20日証協無担保2,600株-80.26%0株0%1,200株-45.45%
2022/05/20日証協有担保75,059株+101.77%141,541株+2111.58%24,500株+42.44%
2022/05/13日証協無担保13,172株-84.84%0株0%2,200株+22.22%
2022/05/13日証協有担保37,200株+675%6,400株0%17,200株+201.75%
2022/05/06日証協有担保4,800株-96.9%0株-100%5,700株-79.27%
2022/04/28日証協無担保86,900株0%0株0%1,800株+63.64%
2022/04/28日証協有担保154,604株-31.2%75,700株-19.04%27,500株-77.05%
2022/04/22日証協無担保0株0%0株0%1,100株+57.14%
2022/04/22日証協有担保224,704株+518.88%93,500株+53.28%119,800株-28.22%
2022/04/15日証協無担保0株-100%0株-100%700株-94.02%
2022/04/15日証協有担保36,308株-90.17%61,000株-40.2%166,892株-22.91%
2022/04/08日証協無担保1,200株-42.86%2,900株0%11,701株-78.67%
2022/04/08日証協有担保369,504株+66.31%102,000株-62.52%216,500株+6.48%

※株式分割は考慮していませんのでご注意ください。

Page Top